文献速递呼吸衰竭与机械通气心脑血管急症

游泳诱发肺水肿的心脏表现:对急性评估的启示

Cardiac Findings in Swimming-Induced Pulmonary Edema: Implications for Acute Assessment.
PubMed 文献 · Chest · 2026-07-10
一句话结论SIPE患者游泳后常见轻度可逆性左室收缩功能受损、肺动脉压升高及心肌生物标志物轻中度升高,ECG无组间差异。

该队列研究纳入2022至2024年瑞典Vansbrosimningen公开水域游泳赛事中45例SIPE患者和45例无症状游泳者(对照),游泳后2小时内及12个月内随访行经胸超声心动图(TTE)、ECG和心脏生物标志物检测。结果显示游泳后TTE左室收缩功能轻度受损在SIPE组占43%、对照组占10%(P=.003),肺动脉收缩压升高在SIPE组占30%、对照组无(P=.005);随访时除1例外TTE异常均改善。游泳后ECG两组无差异(P=.746);高敏肌钙蛋白I升高在SIPE组占67%、对照组占40%(中位数47 pg/mL vs 14 pg/mL,P<.001);NT-proBNP中位数SIPE组169 pg/mL高于对照组65 pg/mL(P<.001)。2例合并心肌梗死的SIPE患者有临床显著胸痛和高水平肌钙蛋白。

要点

  • SIPE患者游泳后TTE可见轻度左室收缩功能受损(43% vs 10%,P=.003)和肺动脉收缩压升高(30% vs 0%,P=.005),随访多改善。
  • 游泳后高敏肌钙蛋白I升高在SIPE组占67%、对照组占40%(中位数47 pg/mL vs 14 pg/mL,P<.001)。
  • 游泳后NT-proBNP中位数SIPE组169 pg/mL高于对照组65 pg/mL(P<.001)。
  • 游泳后ECG两组无差异(P=.746),不能仅凭ECG区分SIPE与无症状游泳者。
  • SIPE合并心肌梗死时可有临床显著胸痛和高水平肌钙蛋白,需警惕并鉴别。

适用人群与场景

  • 参加公开水域游泳赛事(瑞典Vansbrosimningen,2022–2024年)后发生SIPE的患者及无症状游泳者(对照)。

诊断标准与关键阈值

  • 原文未提及SIPE的诊断标准或评分界值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • SIPE患者出现临床显著胸痛和高水平肌钙蛋白时需考虑合并心肌梗死(原文报告2例)。

研究设计与关键结果

  • 研究类型:队列研究;样本量:45例SIPE患者和45例对照;单国(瑞典)公开水域游泳赛事人群。
  • 游泳后TTE左室收缩功能轻度受损:SIPE组43% vs 对照组10%(P=.003);随访时除1例外均改善。
  • 游泳后肺动脉收缩压升高:SIPE组30% vs 对照组0%(P=.005)。
  • 游泳后ECG两组无差异(P=.746)。
  • 游泳后高敏肌钙蛋白I升高:SIPE组67% vs 对照组40%(中位数47 pg/mL vs 14 pg/mL,P<.001)。
  • 游泳后NT-proBNP中位数:SIPE组169 pg/mL vs 对照组65 pg/mL(P<.001)。
  • 2例SIPE合并心肌梗死患者有临床显著胸痛和高水平肌钙蛋白。

证据类型、等级与局限

  • 证据类型:队列研究(ClinicalTrials.gov NCT05391737)。
  • 局限:原文未明确报告证据等级;样本量较小(各45例),单中心/单赛事人群,观察性设计。

对床旁实践的改变

  • SIPE急性评估中,游泳后TTE可见轻度可逆性左室收缩功能受损和肺动脉压升高,随访多改善,可作为预期参考。
  • 游泳后心肌生物标志物(高敏肌钙蛋白I、NT-proBNP)在SIPE患者中可轻中度升高,解读时需结合临床。
  • ECG在SIPE与无症状游泳者间无差异,不能单独用于鉴别。
  • SIPE患者有临床显著胸痛和高水平肌钙蛋白时需警惕合并心肌梗死。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Pathologic cardiac findings have been described in case reports of patients with swimming-induced pulmonary edema (SIPE).

RESEARCH QUESTION: What are the cardiac findings in patients with SIPE and how are they characterized?

STUDY DESIGN AND METHODS: A cohort study evaluated patients with SIPE and asymptomatic swimmers (control participants) participating in Sweden's largest open-water swimming event, Vansbrosimningen, from 2022 through 2024. Transthoracic echocardiogram (TTE), ECG, and cardiac biomarkers were assessed within 2 hours following swimming and at follow-up within 12 months.

RESULTS: In total, 45 patients with SIPE and 45 control participants were included in the study. Systolic ventricular function on TTE was mildly impaired following swimming in 43% of patients and 10% of control participants (P = .003). Systolic pulmonary artery pressure was increased in 30% of patients but in none of the control participants (P = .005). TTE pathology had improved at follow-up in all but 1 patient. Findings on ECG following swimming showed no difference between groups (P = .746). High-sensitivity cardiac troponin I levels following swimming were increased in 67% of patients and 40% of control participants (median, 47 pg/mL vs 14 pg/mL; P < .001). N-terminal pro-B-type natriuretic peptide levels were higher in patients than in control participants (median, 169 pg/mL vs 65 pg/mL; P < .001). Two patients with myocardial infarction concurrently with SIPE had clinically significant chest pain and high levels of cardiac troponin.

INTERPRETATION: In patients with SIPE, transient mildly affected cardiac function on TTE and a small to moderate elevation of cardiac biomarkers is likely to be found. ECG did not differ between groups. This study provides a reference of expected cardiac findings in patients with SIPE.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05391737; URL: www.

CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Seiler C, Torola M, Knuts U, et al. Cardiac Findings in Swimming-Induced Pulmonary Edema: Implications for Acute Assessment. Chest. 2026. PMID: 42431395. doi:10.1016/j.chest.2026.06.051

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。